Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
The current price of Eli Lilly And Co in the market is 41 858,38 ₴, with a 24-hour trading volume of 124,11B ₴. The asset's market cap is 37,46T ₴, after moving 0.02% in the last day.
Tokenized Eli Lilly And Co is trading at 41 902,83 ₴, with a tokenized market cap of 223,27M ₴ and a 24-hour trading volume of 111,85M ₴. The tokenized asset has moved 1.19% in the past 24 hours.